CDH2 and colorectal carcinoma: As shown in Figure 3C, the expression of mesenchymal markers, such as N-cad, Vimentin, Snai1, Zeb, and MMP9, was upregulated, while epithelial markers, such as E-cad and ZO1, were reduced in CRC cells overexpressing VCAM1.